The disease affects948.


The disease affects948.roves Benlysta To treat lupusThe U.S. Food and Drug Administration approved Benlysta in patients with active, autoantibody – positive lupus , the therapy received therapy received therapy, including corticosteroids, antimalarials, immunosuppressives nonsteroidal anti-inflammatory drugs should be treated.

‘Benlysta, with with existing therapies, may be an important new approach to treating health professionals and patients looking to help manage symptoms, which may be associated with this disease,’said Curtis Rosebraugh, director of Office of Drug Evaluation II. Into the FDA Center for Drug evaluation and Research.Honored for pioneering studies of genetic disorders by chemotherapy and tumor developing.

Contacts:Warren Froelich Phone: 215/440-9300 ext 198 E-mail:.Elizabeth J. Tait Phone: 215/440-9300 Ext 144 E-mail:.Silas Deane nation Foundation for Cancer Research Phone: 301/654-1250 ext 105 E-mail:.